Page last updated: 2024-10-25

desipramine and Degenerative Diseases, Central Nervous System

desipramine has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lauterbach, EC1
Victoroff, J1
Coburn, KL1
Shillcutt, SD1
Doonan, SM1
Mendez, MF1
Lin, HY1
Yeh, WL1
Huang, BR1
Lin, C1
Lai, CH1
Lin, H1
Lu, DY1

Reviews

1 review available for desipramine and Degenerative Diseases, Central Nervous System

ArticleYear
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
    The Journal of neuropsychiatry and clinical neurosciences, 2010,Winter, Volume: 22, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzo

2010

Other Studies

1 other study available for desipramine and Degenerative Diseases, Central Nervous System

ArticleYear
Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons.
    PloS one, 2012, Volume: 7, Issue:11

    Topics: Animals; Antidepressive Agents; Cell Death; Cell Nucleus; Cell Survival; Desipramine; Dopaminergic N

2012